In fact, treatment with salvianolic acid, through AKT activation and consequent GSK-3β inhibition, induces NRF2 nuclear accumulation and transcription of target genes that protect the kidney epithelium from the oxidative stress produced during chronic kidney disease (CKD) [134]. This evidence concerns the gene GSK3B and chronic kidney disease.